Given the oncogenic nature of Ephexin1 and the tumor-suppressive function of Axin1, the overexpression of Ephexin1 in CRC suggests that it could counteract the effect of Axin1, thereby promoting cancer progression. This evidence concerns the gene NGEF and colorectal carcinoma.